Complications, Mineral and Vitamin Deficiencies: Comparison between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy


Objective: Nutritional deficiencies are known side-effects of bariatric surgeries, specifically in those that bypass the proximal intestine. Therefore, in clinical practice, vitamin and mineral supplementations are often necessary after such operations. It was our intention to evaluate, whether alimentary deficiencies occur with the same frequency in patients following Sleeve-Gastrectomy (SG) compared to Roux-en-Y Gastric Bypass (RYGB) surgeries. Methods: We conducted a retrospective data analysis of 171 patients (121 RYGB, 50 SG). Vitamin levels were compared between SG and RYGB patients over the first post-operative year. Furthermore, regression analysis was performed with regard to vitamin and iron supplementations and their recommended dosages. Complications occurring within the first post-surgical year were documented as well. Results: Other than vitamin B6 deficiency, which was found to be more frequent in SG patients, there was no other significant difference regarding the type of operation and the number of patients who had these deficiencies. There was no significant difference in average vitamin and iron levels between RYGB and SG. A minimum dose of 1000 IU vitamin D per day was necessary to affect vitamin D levels. The intramuscular administration of vitamin B12 was the only route found to be effective. Complications within the first year were rare. Conclusions: Against common assumptions, vitamin and iron deficiencies in SG patients are not less frequent in the first post-surgical year in comparison to RYGB patients. Standard supplementations should include iron in premenopausal women: Vitamin D at least 1000 IU per day and vitamin B12 i.m. administration in case of a deficiency.

Share and Cite:

N. Sauer, J. Wienecke, C. Wiesfch, S. Wolter, O. Mann and J. Aberle, "Complications, Mineral and Vitamin Deficiencies: Comparison between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy," Surgical Science, Vol. 4 No. 12, 2013, pp. 547-553. doi: 10.4236/ss.2013.412106.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] K. Ben-David and G. Rossidis, “Bariatric Surgery: Indications, Safety and Efficacy,” Current Pharmaceutical Design, Vol. 17, No. 12, 2011, pp. 1209-1217. 1795656828
[2] C. Schweiger and A. Keidar, “Nutritional Deficiencies in Bariatric Surgery Patients: Prevention, Diagnosis and Treatment,” Harefuah, Vol. 149, No. 11, 2010, pp. 715-720, 748.
[3] A. J. Torres and M. A. Rubio, “The Endocrine Society’s Clinical Practice Guideline on Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: Commentary from a European Perspective,” European Journal of Endocrinology, Vol. 165, No. 2, 2011, pp. 171-176.
[4] B. M. Rhode, C. Shustik, N. V. Christou and L. D. Mac-Lean, “Iron Absorption and therapy after Gastric Bypass,” Obesity Surgery, Vol. 9, No. 1, 1999, pp. 17-21. 765553656
[5] R. E. Brolin, J. H. Gorman, R. C. Gorman, et al., “Prophylactic Iron Supplementation after Roux-en-Y Gastric Bypass: A Prospective, Double-Blind, Randomized Study,” Annals of Surgery, Vol. 133, No. 7, 1998, pp. 740-744.
[6] C. D. Smith, S. B. Herkes, K. E. Behrns, V. F. Fairbanks, K. A. Kelly and M. G. Sarr, “Gastric Acid Secretion and Vitamin B12 Absorption after Vertical Roux-en-Y Gastric Bypass for Morbid Obesity,” Annals of Surgery, Vol. 218, No. 1, 1993, pp. 91-96. 7000-00014
[7] K. E. Behrns, C. D. Smith and M. G. Sarr, “Prospective Evaluation of Gastric Acid Secretion and Cobalamin Absorption Following Gastric Bypass for Clinically Severe Obesity,” Digestive Diseases and Sciences, Vol. 39, No. 2, 1994, pp. 315-320.
[8] G. Skroubis, G. Sakellaropoulos, K. Pouggouras, N. Mead, G. Nikiforidis and F. Kalfarentzos, “Comparison of Nutritional Deficiencies after Roux-en-Y Gastric Bypass and after Biliopancreatic Diversion with Roux-en-Y Gastric Bypass,” Obesity Surgery, Vol. 12, No. 4, 2002, pp. 551-558.
[9] S. P. Marcuard, D. R. Sinar, M. S. Swanson, J. F. Silverman and J. S. Levine, “Absence of Luminal Intrinsic Factor after Gastric Bypass Surgery for Morbid Obesity,” Digestive Diseases and Sciences, Vol. 34, No. 8, 1989, pp. 1238-1242.
[10] P. L. Cooper, L. K. Brearley, A. C. Jamieson and M. J. Ball, “Nutritional Consequences of Modified Vertical Gastroplasty in Obese Subjects,” International Journal of Obesity and Related Metabolic Disorders, Vol. 23, No. 4, 1999, pp. 382-388.
[11] E. E. Mason, “Starvation Injury after Gastric Reduction for Obesity,” World Journal of Surgery, Vol. 22, No. 9, 1998, pp. 1002-1007.
[12] S. Fawcett, G. B. Young and R. L. Holliday, “Wernicke’s Encephalopathy after Gastric Partitioning for Morbid Obesity,” Canadian Journal of Surgery, Vol. 27, No. 2, 1984, pp. 169-170.
[13] S. Singh and A. Kumar, “Wernicke Encephalopathy after Obesity Surgery: A Systematic Review,” Neurology, Vol. 68, No. 11, 2007, pp. 807-811. 29648.86
[14] L. C. Chaves, J. Faintuch, S. Kahwage and A. Alencar Fde, “A Cluster of Polyneuropathy and Wernicke-Korsakoff Syndrome in a Bariatric Unit,” Obesity Surgery, Vol. 12, No. 3, 2002, pp. 328-334.
[15] S. Gehrer, B. Kern, T. Peters, C. Christoffel-Courtin and R. Peterli, “Fewer Nutrient Deficiencies after Laparoscopic Sleeve Gastrectomy (LSG) than after Laparoscopic Roux-Y-Gastric Bypass (LRYGB): A Prospective Study,” Obesity Surgery, Vol. 20, No. 4, 2010, pp. 447-453. s11695-009-0068-4
[16] C. W. Compher, K. O. Badellino and J. I. Boullata, “Vitamin D and the Bariatric Surgical Patient: A Review,” Obesity Surgery, Vol. 18, No. 2, 2008, pp. 220-224.
[17] I. Kehagias, S. N. Karamanakos, M. Argentou and F. Kalfarentzos, “Randomized Clinical Trial of Laparoscopic Roux-en-Y Gastric Bypass versus Laparoscopic Sleeve Gastrectomy for the Management of Patients with BMI < 50 kg/m2,” Obesity Surgery, Vol. 21, No. 11, 2011, pp. 1650-1656.
[18] R. E. Brolin and M. Leung, “Survey of Vitamin and Mineral Supplementation after Gastric Bypass and Biliopancreatic Diversion for Morbid Obesity,” Obesity Surgery, Vol. 9, No. 2, 1999, pp. 150-154.
[19] X. Nogués, A. Goday, M. J. Pena, et al., “Bone Mass Loss after Sleeve Gastrectomy: A Prospective Comparative Study with Gastric Bypass,” Cirugía Espanola, Vol. 88, No. 2, 2010, pp. 103-109.
[20] K. Miller, E. Hell, B. Lang and E. Lengauer, “Gallstone Formation Prophylaxis after Gastric Restrictive Procedures for Weight Loss: A Randomized Double-Blind Placebo-Controlled Trial,” Annals of Surgery, Vol. 238, No. 5, 2003, pp. 697-702.
[21] D. Papamargaritis, G. Koukoulis, E. Sioka, et al., “Dumping Symptoms and Incidence of Hypoglycaemia after Provocation Test at 6 and 12 Months after Laparoscopic Sleeve Gastrectomy,” Obesity Surgery, Vol. 22, No. 10, 2012, pp. 1600-1606.
[22] G. J. Service, G. B. Thompson, F. J. Service, J. C. Andrews, M. L. Collazo-Clavell and R. V. Lloyd, “Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery,” The New England Journal of Medicine, Vol. 353, No. 3, 2005, pp. 249-254. Moa043690

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.